Reproductive & melanocortin
Kisspeptin-10
- 10 mg
Custom strengths on request
Not FDA-approved. On FDA's 503A list (May 14, 2026): Category 2, raises significant safety risks. Source, May 14, 2026
At a glance
These dosages are a helpful guide, not a prescription. Every clinician is expected to do their own due diligence before prescribing.
Start
150 nmol/h subcutaneous infusion (portable pump, soft cannula)
Human study
- Frequency
- Once daily, 8 h on / 16 h off
- Route
- subcutaneous infusion (portable pump, soft cannula)
- Course
- 12 days
150 nmol/h is an 8 h pump infusion rate in healthy men, not a bolus dose; the only SC bolus on record (women) was inert.
Get a quote
Custom strengths on request. Prices are quoted per clinic.